American Century Companies’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-135,448
Closed -$2.53M 2420
2022
Q1
$2.53M Sell
135,448
-532,789
-80% -$9.59M ﹤0.01% 1329
2021
Q4
$14.3M Sell
668,237
-1,136,119
-63% -$22.4M 0.01% 786
2021
Q3
$33.3M Buy
1,804,356
+19,077
+1% +$384K 0.02% 552
2021
Q2
$38.2M Buy
1,785,279
+296,518
+20% +$6.03M 0.03% 517
2021
Q1
$28.7M Buy
+1,488,761
New +$26.2M 0.02% 565

Other funds holding OCDX

American Century Companies's OCDX Position: Q2 2022 in Review

American Century Companies sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 135,448 shares — an estimated $2.53M sold.

American Century Companies first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $38.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • American Century Companies reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • American Century Companies sold 135,448 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $2.53M.
  • American Century Companies first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • American Century Companies's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $38.2M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.